A Phase 2 Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Trial Profile

A Phase 2 Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Feb 2017

At a glance

  • Drugs PRM 151 (Primary)
  • Indications Idiopathic pulmonary fibrosis
  • Focus Therapeutic Use
  • Sponsors Promedior
  • Most Recent Events

    • 26 Oct 2016 Status changed from recruiting to active, no longer recruiting.
    • 14 Sep 2015 Planned End Date changed from 6 Dec 2015 to 1 Mar 2019, as reported by ClinicalTrials.gov.
    • 08 Sep 2015 Planned number of patients changed from 60 to 117 according to a Promedior media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top